Nadia N. Laack

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

Paul D. Brown, Karla V. Ballman, Jane H. Cerhan et al. · The Lancet Oncology · 2017 · 1.2K citations · Full text

Medicine, Radiation Oncology, Surgery +17

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

Paul D. Brown, S. Pugh, Nadia N. Laack et al. · Neuro-Oncology · 2013 · 944 citations · Full text

Medicine, Pharmacotherapy, Radiation Oncology +17

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

Paul D. Brown, Vinai Gondi, Stephanie L. Pugh et al. · Journal of Clinical Oncology · 2020 · 830 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

Erica H. Bell, Edward G. Shaw, Jan C. Buckner et al. · Journal of Clinical Oncology · 2020 · 222 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study

D.H. Pafundi, Nadia N. Laack, Ryan S. Youland et al. · Neuro-Oncology · 2013 · 217 citations · Full text

Medicine, Nuclear Medicine, Radiology +17